BMP2 and metabolic dysfunction-associated steatohepatitis: Indeed, when compared with NL, hepatic mRNA levels of BMP2 were significantly higher in patients with NAFL (1.7-fold, p = 0.0323) and NASH (2.6-fold, p < 0.0001) (Fig. 1B), in parallel with the increase of the liver injury.